Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Identifying thrombosis risk in ITP patients

Balitsky AK et al. Blood. 2018 Nov 8. doi: 10.1182/blood-2018-08-868406

Publish date:: December 5, 2018

Key clinical point: The TH2 risk assessment score helped identify patients with immune thrombocytopenia taking anticoagulants who developed thrombosis.

Major finding: The score predicted all seven thrombotic events in the study.

Study details: Retrospective study of 13 patients with ITP.

Disclosures: One researcher reported relationships with Amgen, Novartis, Rigel Pharmaceuticals, UCB, and Principia Biopharma.

Read the article here.

Citation:

Balitsky AK et al. Blood. 2018 Nov 8. doi: 10.1182/blood-2018-08-868406.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,